跳至主要内容
临床试验/NCT00927667
NCT00927667已完成4 期

A Diagnostic Interventional, Controlled, Cross-sectional Evaluation of Joint Status Using Magnetic Resonance Imaging in Subjects With Severe Hemophilia A Treated With Primary Prophylaxis, Secondary Prophylaxis, or On-demand Therapy

Bayer15 个研究点 分布在 6 个国家目标入组 156 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Bayer
入组人数
156
试验地点
15
主要终点
Maximum ankle MRI score

研究概览

简要总结

The joint status (knees, ankles) of patients suffering from severe Hemophilia A (too little blood clotting factor VIII in blood) is evaluated in a single magnetic resonance imaging session. No study medication is given.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
12 Years 至 35 Years(Child, Adult)
性别
Male
接受健康志愿者

入选标准

  • Males aged 12 - 35 years
  • Severe hemophilia A ( < 1 % FVIII:C)
  • No history of Factor VIII inhibitory antibody
  • For prophylaxis groups, having received at least two prophylactic infusions per week for 45 weeks per year for the prevention of bleeding without relevant interruption and continuing until the present.
  • Complete documentation of joints bleeds and their locations prior to start of prophylaxis,
  • Bleeding history and/or treatments received during the last 5 years documented in the subjects medical records.
  • For the on-demand subjects > 12 bleeds/year in the last 5 years.
  • Written informed consent by subject and parent/legal representative, if < 18 years

排除标准

  • Individuals with other coagulopathies (e.g., von Willebrand disease)
  • HIV seropositive subjects
  • Individuals for whom the most clinically severe joint is not one of the 4 index joints (ankle, knee)
  • HCV seropositive individuals who underwent interferon therapy during the last 12 months
  • Individuals for whom high-magnetic exposure is contraindicated (see section 7.1)
  • Synovectomy performed within the six months prior to investigation enrollment or orthopedic surgery planned to be performed within the investigation period
  • Joint replacement
  • For the on-demand treatment group, any period greater than 8 consecutive months having received >/= 50 IU per kg per week Factor VIII for the prevention of bleeding

结局指标

主要结局

Maximum ankle MRI score

时间窗: no timeframe (single visit, "snapshot" of the actual joint status)

次要结局

  • Total MRI score of the maximum index joint(no timeframe (single visit, "snapshot" of the actual joint status))
  • Number of bleeds in each index joint over previous 5 years(no timeframe (medical history status))
  • Number of total joint bleeds and their locations over previous 5 years(no timeframe (medical history status))
  • Physical joint score (Gilbert Score)(no timeframe (single visit, "snapshot" of the actual joint status))

研究者

发起方
Bayer
申办方类型
Industry

研究点 (15)

Loading locations...

相似试验